Clinical trial
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
NCT01396213 is registered in ClinicalTrials.gov with 9 Meters Biopharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 7, 2011
- Completion date
- August 20, 2013
- Enrollment
- 342 (actual)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.